Identifying cellular and molecular differences between human and non-human primates (NHPs) is essential to the basic understanding of the evolution and diversity of our own species. Until now, preserved tissues have been the main source for most comparative studies between humans, chimpanzees (Pan troglodytes) and bonobos (Pan paniscus) 1,2 . However, these tissue samples do not fairly represent the distinctive traits of live cell behaviour and are not amenable to genetic manipulation. We propose that induced pluripotent stem (iPS) cells could be a unique biological resource to determine relevant phenotypical differences between human and NHPs, and that those differences could have potential adaptation and speciation value. Here we describe the generation and initial characterization of iPS cells from chimpanzees and bonobos as new tools to explore factors that may have contributed to great ape evolution. Comparative gene expression analysis of human and NHP iPS cells revealed differences in the regulation of long interspersed element-1 (L1, also known as LINE-1) transposons. A force of change in mammalian evolution, L1 elements are retrotransposons that have remained active during primate evolution 3-5 . Decreased levels of L1-restricting factors APOBEC3B (also known as A3B) 6 and PIWIL2 (ref. 7) in NHP iPS cells correlated with increased L1 mobility and endogenous L1 messenger RNA levels. Moreover, results from the manipulation of A3B and PIWIL2 levels in iPS cells supported a causal inverse relationship between levels of these proteins and L1 retrotransposition. Finally, we found increased copy numbers of species-specific L1 elements in the genome of chimpanzees compared to humans, supporting the idea that increased L1 mobility in NHPs is not limited to iPS cells in culture and may have also occurred in the germ line or embryonic cells developmentally upstream to germline specification during primate evolution. We propose that differences in L1 mobility may have differentially shaped the genomes of humans and NHPs and could have continuing adaptive significance.
Identifying cellular and molecular differences between human and non-human primates (NHPs) is essential to the basic understanding of the evolution and diversity of our own species. Until now, preserved tissues have been the main source for most comparative studies between humans, chimpanzees (Pan troglodytes) and bonobos (Pan paniscus) 1, 2 . However, these tissue samples do not fairly represent the distinctive traits of live cell behaviour and are not amenable to genetic manipulation. We propose that induced pluripotent stem (iPS) cells could be a unique biological resource to determine relevant phenotypical differences between human and NHPs, and that those differences could have potential adaptation and speciation value. Here we describe the generation and initial characterization of iPS cells from chimpanzees and bonobos as new tools to explore factors that may have contributed to great ape evolution. Comparative gene expression analysis of human and NHP iPS cells revealed differences in the regulation of long interspersed element-1 (L1, also known as LINE-1) transposons. A force of change in mammalian evolution, L1 elements are retrotransposons that have remained active during primate evolution [3] [4] [5] . Decreased levels of L1-restricting factors APOBEC3B (also known as A3B) 6 and PIWIL2 (ref. 7) in NHP iPS cells correlated with increased L1 mobility and endogenous L1 messenger RNA levels. Moreover, results from the manipulation of A3B and PIWIL2 levels in iPS cells supported a causal inverse relationship between levels of these proteins and L1 retrotransposition. Finally, we found increased copy numbers of species-specific L1 elements in the genome of chimpanzees compared to humans, supporting the idea that increased L1 mobility in NHPs is not limited to iPS cells in culture and may have also occurred in the germ line or embryonic cells developmentally upstream to germline specification during primate evolution. We propose that differences in L1 mobility may have differentially shaped the genomes of humans and NHPs and could have continuing adaptive significance.
Humans, chimpanzees and bonobos are genetically very similar, sharing nearly 98% of their alignable genomic sequence [1] [2] [3] . However, cellular and molecular phenotypes, especially at identical stages of development, are difficult to establish, mainly owing to limited access to embryonic material from humans and NHPs 8 . We reprogrammed fibroblasts from two bonobos and two chimpanzees into iPS cells as previously described 9, 10 (Extended Data Fig. 1a ). After culture in human embryonic stem (ES) cell-supporting conditions, NHP iPS cell colonies could be distinguished by the high nucleus-to-cytoplasm ratio morphology. iPS cell clones from both species continuously expressed pluripotency markers, retained an undifferentiated morphology in culture, and maintained a normal karyotype (Fig. 1a ). After embryoid-body-mediated differentiation in vitro, clones contained tissue derivatives from the three embryonic germ layers and downregulated expression of pluripotency markers ( Fig. 1b ). iPS-cell-selected clones were also able to differentiate into the three embryonic germ layers in vivo, as shown by analysis of teratomas in nude mice ( Fig. 1c ).
Together, these data demonstrate that NHP iPS cell clones re-established pluripotency at the molecular and cellular levels.
To gain insight into differences in gene expression between human and NHP iPS cells, we performed high-throughput RNA sequencing (RNA-seq) analyses on four human, two chimpanzee and two bonobo iPS cell lines (Extended Data Fig. 1b ). The expression profiles of iPS cells from the three species clustered together with human ES cells (HUES6 and H1), and were distinguishable from ES-cell-derived neural progenitor cells ( Fig. 2a ); chimpanzee and bonobo iPS cells clustered closer to each other than to human iPS cells ( Fig. 2a ). We then performed pairwise comparisons of protein-coding gene expression levels ( Fig. 2b ). Venn diagrams in Fig. 2b represent expressed genes with non-significant differences between species (purple), and upregulated genes with estimated false discovery rates (FDR) of less than 5% and a fold change greater than twofold (pale orange and blue). Comparison between humans and NHPs (Fig. 2b , bottom right) revealed 1,376 genes with increased expression in human iPS cells, and 1,042 common genes with increased expression in NHP iPS cells, whereas no significant differences were observed in 11,585 protein-coding genes. Next, we focused on genes differentially expressed between human and NHP iPS cells ( Fig. 2c -e and Extended Data Fig. 1c, d) , and found, among the top 50 genes with increased expression in human compared to NHP iPS cells, two genes involved in the restriction of L1 retrotransposition, namely A3B and PIWIL2 ( Fig. 2d ).
Active, full-length L1 elements have the ability to move from one location in the genome to another by a copy-paste mechanism known as retrotransposition 11 . Active L1 elements have been detected in both germline and somatic tissues, and can affect genome integrity 12, 13 . As uncontrolled retrotransposition activity can be deleterious to the host 14 , organisms have evolved mechanisms to control L1 mobility 11 . A3B is a member of the APOBEC3 family of cytidine deaminases that can inhibit L1 mobility in different cell types, including human ES and iPS cells, via a still unclear mechanism 6, 15, 16 . PIWIL2 is an effector of the Piwi-interacting RNA (piRNA) pathway involved in L1 silencing mainly in the germ line 7 .
To confirm differences in A3B and PIWIL2 in human versus NHP iPS cells, we first cloned their complementary DNAs from the three species, and found a high degree of conservation between humans and NHPs (Extended Data Fig. 2 ). Quantification of A3B mRNA levels by 
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quantitative PCR (qPCR) confirmed significantly higher levels (,30fold) of A3B in both human iPS cell lines compared to NHP iPS cells ( Fig. 3a ). Levels of PIWIL2 mRNA were 16-fold higher in human than in NHP iPS cell lines ( Fig. 3b ). PIWIL2-mediated control of transposons is most active in the germ line, and we observed that levels of PIWIL2 mRNA are 20-40-fold lower in human iPS cells than in the testis (Extended Data Fig. 3a) . The increased expression observed in human iPS cells seems to be specifically restricted to A3B and PIWIL2 compared to other members of these protein families (Extended Data Fig. 3b , c). Differences in A3B and PIWIL2 mRNA levels reflected higher A3B and PIWIL2 protein levels in human versus NHP iPS cells ( Fig. 3c ). Ectopic expression of A3B has been shown to inhibit the mobility of human L1 reporter elements 6, [17] [18] [19] (Extended Data Fig. 4a ). In 293T cells, ectopic expression of human A3B significantly reduced L1expressing firefly luciferase 18, 19 mobility by fivefold compared to control plasmid or a plasmid expressing A3G, another APOBEC3 protein that lacks anti-L1 activity 17 (Fig. 3d ). We also found a significant decrease in L1-luciferase retrotransposition in cells overexpressing PIWIL2 compared to control transfected cells ( Fig. 3d ). We then confirmed that human L1 can retrotranspose in human ES and iPS cells under our culture conditions, as previously shown 15, 20, 21 (Fig. 3e ). Because we found reduced levels of L1 restriction factors A3B and PIWIL2 in NHPs, we compared L1 activity in human versus NHP iPS cells using human L1 tagged with the enhanced green fluorescent protein (eGFP) reporter element 18, 19 . L1 retrotransposition was significantly higher in NHP compared to human iPS cell lines, with 10-and 8-fold increases in eGFP-positive cells in chimpanzee and bonobo iPS cells, respectively ( Fig. 3f, g) . To test whether the differential L1 regulation in iPS cells is specific to human L1, we measured the activity of an NHP L1 element in iPS cells. We generated a retrotransposition-competent chimpanzee L1-eGFP reporter element (chimp-L1) (Extended Data Fig. 5 ), and observed that chimp-L1 was significantly more active in NHP than in human iPS cells ( Fig. 3h ), suggesting that the decreased L1 activity in human iPS cells is not specific to the human L1 element, and that human iPS cells are more efficient in repressing L1 retrotransposition than NHP iPS cells.
To analyse the contribution of endogenous A3B to the differential L1 activity observed among primate cells, we generated human ES and iPS cells with decreased levels of A3B ( Fig. 4a and Extended Data Fig. 4b, c ). Stable short hairpin RNA (shRNA)-mediated knockdown of A3B (shA3B) resulted in a significant increase in L1-eGFP activity compared to scramble (shScr) control cells in human iPS cells ( Fig. 4a, b ). Knockdown was specific to A3B, not affecting other APOBEC3 proteins (Extended Data Fig. 4d-f ). As expected, L1 mobility was significantly decreased in both chimpanzee and bonobo iPS cell lines after A3B overexpression ( Fig. 4c ). Similarly, overexpression of chimpanzee or bonobo PIWIL2 in NHP iPS cells reduced L1 mobility to levels detected in human iPS cells ( Fig. 4d ). We did not observe differences in the levels of L1-eGFP mRNA expressed from transfected L1 plasmid or in L1 promoter activity between human and NHP iPS cells (Extended Data Fig. 4g -i). Together, these results suggest that differences in A3B and PIWIL2 expression levels contribute to higher L1 retrotransposition in NHP than in human iPS cells.
PIWIL2 repression of transposons is mediated through piRNAs 22 . Thus, we analysed the presence of PIWIL2-bound piRNAs in doxycycline-inducible human iPS cells expressing Flag-tagged PIWIL2 by immunoprecipitation and subsequent 59 end labelling. Analysis of PIWIL2-associated small RNAs revealed the presence of ,26-30nucleotide RNAs only in cells expressing Flag-PIWIL2 but not in control cells or in pulldowns with control antibody ( Fig. 4e and Extended Data Fig. 6a, b ). Next, to probe for the presence of L1-targeting-piRNAs, we characterized the small RNA populations in human iPS cells by small RNA-seq analysis (Extended Data Fig. 6c, d and Supplementary Tables 1 and 2 ). We detected 272 and 229 annotated piRNAs in human iPS cell lines 1 and 2, respectively (Extended Data Fig. 6d-f and Supplementary Table 2 ). In addition, we observed a number of 26-33-nucleotide small RNAs mapping to the consensus human-specific L1 element (L1 Homo sapiens; L1Hs) sequence ( Fig. 4 and Extended Data Fig. 7a, b) , including 12 and 10 of the 37 annotated piRNAs mapping to L1Hs in piRNAbank (http://pirnabank.ibab.ac.in/) in hiPS cell lines 1 and 2, respectively (Extended Data Figs 6e, g and 7a-c). Together, these results demonstrate the presence of piRNAs complementary to L1Hs in human iPS cells.
We then asked whether different levels of L1 reporter mobility between human and NHP iPS cells reflect differences in endogenous L1 activity. First, we analysed endogenous L1 RNA levels by qPCR, and found higher levels of endogenous L1 mRNA in chimpanzee and bonobo than in human iPS cells ( Fig. 4g and Extended Data Fig. 8a-c ). Next, we examined the number of L1 elements in human and chimpanzee genomes to assess differences in recent L1 mobility. We did not observe major differences in the number of L1 elements for older families (L1PA4, L1AP3 and L1PA2; approximately 18, 12.5 and 7.6 million years old, respectively) 23, 24 (Fig. 4h ). However, we did observe significantly higher numbers of chimpanzee-specific L1 elements (L1 Pan troglodytes; L1Pt) compared to L1Hs elements 25, 26 (Fig. 4h) . Differences in the expression of A3B and PIWIL2 suggest that L1 mobility may 
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have been altered at a relatively recent evolutionary divergence. Therefore, using divergence as a measurement of L1 age, we estimated the number of species-specific L1 loci, and found that the number of chimpanzee-specific loci was significantly higher than the number of human-specific loci ( Fig. 4i and Extended Data Fig. 8d-g) . This increased number of species-specific L1 loci in chimpanzee suggests that endogenous L1 has been more active in NHP genomes, correlating with the decreased levels of A3B and PIWIL2.
Here we show that iPS cells from both chimpanzees and bonobos have increased L1 mobility. Different rates of L1 activity could lead to considerable changes in genomic structure and function, and could potentially affect adaptation. The human population has gone through one or more bottlenecks throughout evolution that might have contributed to decreased genetic diversity 27 . Chimpanzees and bonobos, in contrast, have increased levels of genetic diversity when compared to humans 28 . This idea is also supported by data showing that there is substantially more genetic difference among individuals within chimpanzee troops in West Africa than among all living humans 29 . Although it remains unclear what the main generators of the phenotypic differences between us and our closest living relatives are (despite the extreme genetic similarity), we propose that L1 mobility could be involved in differentially shaping the genomes of humans and NHPs, providing an extra layer of variability to the latter. In fact, recent studies have suggested that ongoing L1 retrotransposition may contribute to inter-individual genetic variation 30 . In this work we also present a new perspective on the use of iPS cell technology as a powerful tool for the study of early stages of development and possible validation of evolutionary genomic and transcriptomic modifications that identify humans as outliers among primates. The iPS cells from great apes that we describe here can also be used for comparative studies of any derivative pluripotent or terminally differentiated cell types, limited solely by the availability of differentiation protocols.
METHODS SUMMARY
Reprogramming of fibroblast was performed by transduction with retroviral vectors expressing OCT4 (also known as POU5F1), MYC, KLF4 and SOX2 human cDNAs. For RNA-seq, libraries from polyA 1 RNA and small RNA were generated using the Illumina TruSeq RNA and Small RNA TruSeq Sample Prep kits, respectively, and analysed on an Illumina HiSeq 2000 sequencer. L1 reporter assays were performed as previously described 18, 19 . Quantification of L1-derived genomic 
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sequences was based on Repbase defined elements annotated by RepeatMasker (http://www.repeatmasker.org). L1 genomic positions for human (hg19, GRCh37) and chimpanzee (panTro3, CGSC 2.1.3) genomes were downloaded from the UCSC Genome Browser annotation database. To identify reference L1 elements that were inserted into the genome after the last common ancestor for human and chimpanzee, L1 elements were mapped between homologous regions of each genome using the UCSC LiftOver tool.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Cell culture and retrovirus infection. Human ES cells HUES6 and H1, human iPS cell lines WT-33, ADRC-40 (human iPS cell lines 1 and 2 in this work, respectively) and WT-126 were previously described 31 . Fibroblasts from human GM22159 (WT-9), P. troglodytes (chimpanzees: PR00818 and PR01209) and P. paniscus (bonobos: AG05253 and PR01086) were from Coriell Cell Repositories (NJ) (Extended Data Table 1 ). All fibroblasts were cultured in MEM (Invitrogen) supplemented with 10% FBS (HyClone Laboratories). Retroviral vectors expressing OCT4 (also known as POU5F1), MYC, KLF4 and SOX2 human cDNAs from Yamanaka's group 9 were obtained from Addgene. Recombinant viruses were produced by transient transfection in 293T cells, as previously described 32 . Two days after infection, cells were plated on mitotically inactivated mouse embryonic fibroblasts (Chemicon) with human ES cell medium. After 2-4 weeks, iPS cell colonies were picked manually and directly transferred to feeder-free conditions on matrigel-coated dishes (BD) using mTeSR1 (StemCell Technologies). Established iPS cell colonies were kept in feeder-free conditions indefinitely, and passed using mechanical dissociation. Embryoid-body-mediated differentiation in suspension was carried out for 10 days in the absence of growth factors. The use of chimpanzee and bonobo fibroblast samples was approved by the US Fish and Wildlife Service, under the permit MA206206. Protocols describing the use of iPS and human ES cells were previously approved by the University of California, San Diego (UCSD), the Salk Institute Institutional Review Board and the Embryonic Stem Cell Research Oversight Committee 31 . To generate stable shA3B cells lines, HUES6, WT-33 and ADRC-40 cells were transduced with lentiviruses expressing shRNAs and selected for puromycin resistance. pLKO.1-based lentiviral plasmids encoding shRNAs against A3B (RHS3979-99216651 and RHS3979-99216658) were obtained from Open Biosystems. Recombinant lentiviruses were produced by transient transfection on 293T cells as previously described 33 .
Teratoma formation in nude mice. Around 1 3 10 6 -3 3 10 6 cells were injected subcutaneously into the dorsal flanks of nude mice (CByJ.Cg-Foxn1nu/J) anaesthetized with isoflurane. Five to six weeks after injection, teratomas were dissected, fixed overnight in 10% buffered formalin phosphate and embedded in paraffin. Tissues were then prepared for histopathologic analysis by the UCSD Mouse Phenotyping Services (http://mousepheno.ucsd.edu). In brief, the tissue was sectioned and stained with haematoxylin and eosin. Control mice injected with fibroblasts failed to form teratomas.
Karyotyping. Standard G-banding chromosome analysis was performed by Cell Line Genetics. Diploid human cells with 2n 5 46 chromosomes; bonobo and chimpanzee with 2n 5 48 chromosomes. RNA extraction and RT-PCR. Total cellular RNA was extracted from ,5 3 10 6 cells using the RNeasy Protect Mini kit or RNeasy Plus kit (Qiagen), according to the manufacturer's instructions, and was reverse transcribed using the SuperScript III First-Strand Synthesis System RT-PCR from Invitrogen. For iPS cell markers, cDNA was amplified by PCR using Accuprime Taq DNA polymerase system (Invitrogen). Primer sequences are shown in Extended Data Table 1 . PCR products were separated by electrophoresis on a 2% agarose gel, stained with ethidium bromide and visualized by ultraviolet illumination. Total RNA samples from human testis were obtained from Clontech. Small RNA was extracted using the mirVana kit (Ambion). Quantitative RT-PCR. RNA was extracted using a QIAGEN RNeasy Plus kit or TRIzol (Life Technologies) and then retrotranscribed to cDNA with the Superscript III First-Strand synthesis system (Invitrogen). qRT-PCR reactions were carried out using SYBR Green mix (Roche) or TaqMan Assays (Life Technologies) using ABI Prism 7900HT sequence detection system (Applied Biosystems). The primers and Taqman sets used in this work are described in Extended Data Table 1 . Data analysis was performed with SDS 2.3 software (Applied Biosystems). Primer efficiency was verified by linear regression to the standard curve. Values were normalized to GAPDH, HPRT or ACTB. Reactions were carried out in triplicate and data were analysed using the comparative (DDC t ) method. For A3B and PIWIL2, RNA levels were normalized to GAPDH or ACTB and represented as relative to iPS cell line 1. Relative A3B and PIWIL2 mRNA levels normalized to GAPDH for each individual iPS cell line and fibroblasts are shown in Extended Data Fig. 9 . The reduced levels of A3B in NHP iPS cell were not due to an A3B deletion polymorphism previously described in human individuals 34 (data not shown). For L1 RNA qRT-PCR, values representing the average of relative levels for L1 RNA (59 UTR, ORF1 and ORF2) were calculated and normalized to actin mRNA levels. L1 levels are shown relative to iPS cell line 1. qRT-PCR analysis of L1-reporter expression in iPS cell lines transfected with L1-eGFP plasmid was carried out 60-72 h after transfection. At this time after transfection, eGFP RNA expressed from retrotransposed L1-eGFP will be insignificant compared to L1-eGFP plasmid-driven expression. eGFP levels were normalized to GAPDH or puromycin. L1-eGFP contains a puromycin expression cassette under PGK promoter control. Thus, puromycin expression can be used as normalizer for transfection.
iPS cells from two different individuals per species were transfected, and eGFP levels are shown relative to human iPS cells. Plasmids. Human A3B cDNA from WT-33 and ADRC-40 iPS cells was amplified using Phusion high-fidelity polymerase (New England BioLabs), and primers are described in Extended Data Table 1 . A3B cDNA fused to a haemagglutinin (HA) tag was then inserted into KpnI/XbaI-digested pcDNA3.11 (pcDNA3-A3B) as previously described 35 . Similarly, PIWIL2 cDNAs were amplified from human and NHP iPS cells as described above and inserted into pEF-BOS-EX using EcoRI/SalI (ref. 36 ). The plasmid expressing APOBEC3G was previously described 35 .
RNA library generation and deep sequencing. PolyA 1 RNA was fragmented and prepared into sequencing libraries using the Illumina TruSeq RNA sample preparation kit and analysed on an Illumina HiSeq 2000 sequencer at the UCSD Biomedical Genomics Laboratory (BIOGEM). cDNA libraries were prepared from four human, two chimpanzee and two bonobo iPS cell lines derived from fibroblasts (two clones each, except for human WT-9 and WT-126 ), and two human ES cell lines (HUES6 and H1). Libraries were sequenced using paired-end 23 100-bp (base pair) reads at a depth of 15-30 million reads per library (250 6 25 bp (mean 6 s.d.) fragments) (Extended Data Fig. 1b ). Paired end reads from all libraries were mapped to both the human (hg19, GRCh37) and chimpanzee (panTro3, CGSC 2.1.3) genomes using STAR (v2.2.0c) 37 . To compare gene expression between human and NHP iPS cells, we first mapped paired end reads from all libraries to both human and chimpanzee genomes and then calculated gene expression read counts relative to human RefSeq transcripts. Owing to the lack of annotation in the chimpanzee genome, human gene models (RefSeq) were used to quantify gene expression. To avoid bias introduced by genome insertions and deletions, only reads mapping to both the human and chimpanzee genomes uniquely were used from each sample when comparing gene expression values (,4% of reads mapped to only one genome per sample). To calculate gene expression, read counts in the exons of RefSeq transcripts where calculated using HOMER 38 . Gene expression clustering was carried out using Gene Cluster 3.0 and visualized with Java Tree View 39, 40 . EdgeR was used to identify differentially expressed genes comparing human samples with NHPs, and pairwise between bonobo, chimpanzee and human 41 . Functional enrichment analysis was restricted to differentially expressed coding genes with false discovery rates less than 5% and a fold change greater than twofold. We further restricted genes to contain an average of ten normalized reads across sample groups to remove genes with very low expression. Gene Ontology functional enrichment for biological processes (level 2) was carried out using DAVID 42 , Homo sapiens whole genome was set as background.
Small RNA library generation and deep sequencing. Small RNA (15-40nucleotide) libraries were prepared using the Illumina TruSeq Small RNA sample preparation kit and analysed on an Illumina HiSeq 2000 sequencer at the Beijing Genomics Institute. Libraries were sequenced using single-end reads at a depth of 15-25 million reads per library. Adaptor sequences were clipped from the 39 end of each read and then aligned to the human (hg19, GRCh37) genome or to the L1Hs consensus sequence (Repbase 43 ) using Bowtie2 (v4.1.2) 44 . Reads aligning to miRBasedefined microRNA transcripts were quantified using HOMER. Matches to previously identified human piRNAs were restricted to small RNAs with lengths between 26 and 33 nucleotides with 59 ends within 2 nucleotides of previously identified piRNA 59 ends based on piRNABank (http://pirnabank.ibab.ac.in/) 45 . L1 retrotransposition. Reporter L1 elements are tagged with a reporter gene (eGFP or firefly luciferase) such that only cells that complete a round of retrotransposition will express the reporter gene 46 . Three L1 reporter plasmids were used in this work. L1-eGFP 18, 46 was previously described and was a gift from J. V. Moran. L1-luciferase-tagged plasmids (pYX014 and pYX017) 19 were obtained from W. An. In pYX014, L1 is regulated by its native promoter (59 UTR) and, in pYX017, by the heterologous promoter CAG. pYX014 and pYX017 plasmids contain a Renilla luciferase expression cassette that allows for control of transfection efficiency. L1 assays in 293T cells were carried out as previously described 47 .
293T cells were transfected with L1 reporter plasmid together with control plasmid or plasmids expressing A3B, A3G or PIWIL2 using polyethylenimine (PEI). L1luciferase retrotransposition was measured by quantification of luciferase activity using the Dual-Glo luciferase reporter assay (Promega) and normalized to Renilla luciferase. L1-luciferase inhibition in the presence of A3B or PIWIL2 was independent of the promoter driving L1 expression (data not shown). Inhibition levels of L1 retrotransposition by A3B and PIWIL2 were comparable between the three L1 reporter plasmids used in this study. Plasmid transfections of iPS cells were performed by electroporation of L1-eGFP plasmid following the manufacturer's instructions (Lonza/Amaxa Nucleofactor, Kit V). The cells were then cultured under normal conditions for 10 days and the percentage of retrotransposition was measured by FACS of eGFP-positive cells. Electroporation efficiency of the L1-eGFP plasmid in human and NHP iPS cell was controlled by transfecting a cassette expressing eGFP and analysed by FACS after RESEARCH LETTER 48 h. Human and NHP iPS cell lines had similar transfection efficiency rates. To test the effect of A3B and PIWIL2 overexpression on L1 activity in NHP iPS cells, human A3B and human, chimpanzee or bonobo PIWIL2 cDNAs were electroporated. All experiments were performed at least three times independently. L1 mobility assays are shown as relative value compared to control plasmid transfections or human iPS cell line 1 and represented as mean 6 s.e.m. of at least three independent experiments. Identification and cloning of a retrotransposition-competent chimpanzee L1. To clone an intact L1 and generate a chimpanzee L1-eGFP reporter plasmid, we followed a modification of the strategy previously described 48 . Intact L1Pt elements were identified in the chimpanzee genome (CSAC 2.1.4/panTro4, UCSC) through Blat and L1Xplorer analyses 49 . Among the identified intact full-length L1Pt elements, we amplified the L1 element located in chromosome 7:11771100-11777132 of the chimpanzee genome from 0.2 ng of genomic DNA extracted from chimpanzee iPS cell 1. Primers were designed to match unique sequences flanking 59 and 39 of the L1Pt and PCR reactions were performed using Phusion High-Fidelity polymerase (NEB). PCR product was sequenced to confirm intactness (Extended Data Fig. 5 ). A second PCR was performed using the first PCR product as template to introduce a NotI site upstream of the 59 end of L1Pt. The second PCR product was digested with NotI/BstZ17I (New England Biolabs) and inserted into NotI/BstZ17I-digested pL1-eGFP replacing the human-L1 element to generate L1IN71 using the Rapid Ligation kit (Roche). L1IN71 contains a full-length L1Pt element tagged with the eGFP retrotransposition reporter cassette. Primers used for cloning L1IN71 are show in Extended Data Table 1 . L1 promoter activity. Human and chimp L1 promoters (L1 59 UTR) were amplified by PCR from L1-eGFP and L1IN71 plasmids, and inserted into XhoI/HindIII digested pGL4.10 (Promega) upstream firefly luciferase cDNA (L1 59 UTR plasmids). To quantify L1 promoter activity, L1 59 UTR plasmids were co-transfected into human and NHP iPS cell lines with a plasmid expressing Renilla luciferase. Seventy-two hours after transfection, luciferase activity was quantified and firefly luciferase signal was normalized to the Renilla luciferase signal. Results are shown as relative to human L1 59 UTR activity in human iPS cells. Two iPS cell lines from different individuals (iPS cell 1 and 2) per species were transfected. Primers used for cloning L1 59 UTRs are show in Extended Data Table 1 . Quantification of reference genome-encoded L1 insertions. Quantification of L1-derived genomic sequences was based on Repbase defined elements annotated by RepeatMasker (http://www.repeatmasker.org). L1 genomic positions for human (hg19, GRCh37) and chimpanzee (panTro3, CGSC 2.1.3) genomes were downloaded from the UCSC Genome Browser annotation database 50 . Owing to the large number of unfinished gaps in the chimpanzee genome assembly greater than 2 kilobases (kb) in size, only truncated L1 elements between 100 bp and 1 kb in length were considered in this analysis. Most of these represented the 39 end of L1 elements. L1 elements were separated based on their annotation as L1HS, L1Pt, L1PA2, L1PA3 or L1PA4 and were plotted as a histogram relative to their divergence values, which indicates the fractions of nucleotides that are mutated relative to the consensus element for each family. To estimate the variability of L1 coverage across the genome, each genome was fragmented into 1 megabase (Mb) sections and then was randomly sampled in ten separate groups to calculate the standard deviation in number of L1 elements across different regions of the genome. A strong concentration of L1 elements in a few specific regions of the genome would result in a very high variance between groups, whereas uniform insertion across the genome would result in a low variance. This standard deviation between each sampling was reported as a function of divergence for each class of L1 elements.
To identify reference L1 elements that were inserted into the genome after the last common ancestor for human and chimpanzee, L1 elements were mapped between homologous regions of each genome using the UCSC LiftOver tool. If an element failed to map between genomes, the 100 bp regions immediately upstream and downstream of the L1 element were also mapped between genomes using the LiftOver tool. If the upstream and downstream regions both mapped to the other genome, then the L1 element was mostly likely a result of a recent insertion. If only one or neither of the upstream and downstream regions mapped between genomes, the region was more likely to be the result of a genomic duplication or deletion and was discarded from the analysis. Error bars (s.d.) represent the differences in L1 density based on the sampling of different genomic regions and represents the variability of L1 coverage across the genomes. Immunocytochemistry. Cells were fixed in 4% paraformaldehyde and then permeabilized with 0.5% Triton X-100 in PBS. Cells were then blocked in 5% donkey serum for 1 h before incubation with primary antibody overnight at 4 uC. After three washes with PBS, cells were incubated with secondary antibodies conjugated to fluorophors (Jackson Immuno Research) for 1 h at room temperature. Fluorescence was detected using a Zeiss inverted microscope. Immunoblotting. Immunoblotting was performed as previously described 35 . Cell pellets were lysed in lysis buffer supplemented with Complete protease inhibitor Extended Data Figure 3 | mRNA levels of APOBEC3 and PIWI-like protein family members in iPS cells. a, Comparative analysis of PIWIL2 mRNA levels. qRT-PCR analysis of PIWIL2 mRNA levels in human testis, human iPS cell lines, and available fibroblasts from which the iPS cell lines were derived. mRNA levels were normalized to GAPDH and shown relative to human testis (mean 6 s.e.m.; n 5 3 biological replicates). Compared to testis, PIWIL2 levels are 20-40 fold lower in iPS cells and ,1,100-fold lower in fibroblasts. b, c, Quantification of mRNA levels of APOBEC3 and PIWI-like family members in human and NHP iPS cells by RNA-seq. Increased mRNA levels in human iPS cells are restricted for APOBEC3B and PIWIL2. y axes in b and c denote the reads per kilobase per million mapped reads (RPKM).
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